Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2021

Mar 19, 2021

33625_dirs_2021-03-19_dc90149b-6b38-4088-a6d2-c530b67a5370.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-17

Reporting Person: Taylor Brenton (EVP, Engineering)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-17 Common Stock M 14765 $16.62 Acquired 71698 Direct
2021-03-17 Common Stock S 6200 $51.2111 Disposed 65498 Direct
2021-03-17 Common Stock S 8565 $51.9377 Disposed 56933 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-17 Stock Option (Right to Buy $16.62 M 14765 Disposed 2021-03-31 Common Stock (14765) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 842 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020

F2: Represents the weighted average share price of an aggregate total of 6,200
shares sold in the price range of $50.60 to $51.59 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 8,565
shares sold in the price range of $51.62 to $52.24 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.

F5: Previously filed form 4s incorrectly listed the expiration date as 04/01/2024.